Literature DB >> 7710953

A new human breast cancer cell line, KPL-1 secretes tumour-associated antigens and grows rapidly in female athymic nude mice.

J Kurebayashi1, M Kurosumi, H Sonoo.   

Abstract

We recently established a new human breast cell line, designated KPL-1, which was derived from the malignant effusion of a patient with breast cancer. This cell line is highly tumorigenic and grows rapidly in female nude mice. Cytogenetic analysis indicated its human origin and revealed a hypertriploid modal number of chromosomes. Electron microscopic examination suggested that the KPL-1 cells are of epithelial origin. Immunohistochemical studies revealed that the cells express cytokeratin, carcinoembryonic antigen and CA 15-3. They also possess a large number of oestrogen receptors but not progesterone receptors. Interestingly, KPL-1 cells seem to grow oestrogen independently in vitro. No amplification of c-erbB-2, c-myc, H-ras and N-ras genes was detected. KPL-1 cells secrete a large amount of tissue polypeptide antigen (TPA). Although the secretion of CA 15-3 seemed to be constant throughout all cell growth phases, TPA secretion increased during the exponential growth phase and decreased during the plateau phase. Serum TPA levels significantly correlated with the volume of KPL-1 tumours transplanted into nude mice. These data suggest that this KPL-1 cell line may be useful for studying oestrogen-independent growth and the kinetics of tumour-associated antigens in vivo as well as in vitro.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7710953      PMCID: PMC2033762          DOI: 10.1038/bjc.1995.163

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  Expression of epidermal growth factor receptor in human gastric and colonic carcinomas.

Authors:  W Yasui; H Sumiyoshi; J Hata; T Kameda; A Ochiai; H Ito; E Tahara
Journal:  Cancer Res       Date:  1988-01-01       Impact factor: 12.701

2.  Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer.

Authors:  J Kurebayashi; T Ishida; Y Higashi; K Suemasu; C Nomoto; K Yoshida
Journal:  Jpn J Clin Oncol       Date:  1990-09       Impact factor: 3.019

3.  Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice.

Authors:  J E Price; A Polyzos; R D Zhang; L M Daniels
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

4.  Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.

Authors:  R Clarke; N Brünner; B S Katzenellenbogen; E W Thompson; M J Norman; C Koppi; S Paik; M E Lippman; R B Dickson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples.

Authors:  L C Murphy; H Dotzlaw
Journal:  Mol Endocrinol       Date:  1989-04

Review 6.  Genetic events in breast cancer and their clinical correlates.

Authors:  S R Wolman; P J Dawson
Journal:  Crit Rev Oncog       Date:  1991

Review 7.  7th Jan Waldenström Lecture. The biology of human cancer metastasis.

Authors:  I J Fidler
Journal:  Acta Oncol       Date:  1991       Impact factor: 4.089

8.  Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration.

Authors:  M M Gottardis; V C Jordan
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

9.  Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancer.

Authors:  M Gion; R Mione; C Gatti; R Dittadi; A Leon; C Castiglioni; O Nascimben; G Bruscagnin
Journal:  Breast Cancer Res Treat       Date:  1990-11       Impact factor: 4.872

10.  Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA15.3 and MCA.

Authors:  M Gion; R Mione; C Gatti; R Dittadi; A Leon; O Nascimben; B Pizzorno; G Bruscagnin
Journal:  Tumori       Date:  1990-08-31
View more
  19 in total

1.  Development and characterization of new immortalized human breast cell lines

Authors: 
Journal:  Cytotechnology       Date:  1998       Impact factor: 2.058

2.  Serum tumor marker kinetics and the clinical course of patients with advanced breast cancer.

Authors:  H Sonoo; J Kurebayashi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  Immunobead filtration: a novel approach for the isolation and propagation of tumor cells.

Authors:  P D Rye; H K Høifødt; G E Overli; O Fodstad
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

4.  Combined treatment with glucagon-like peptide-1 receptor agonist exendin-4 and metformin attenuates breast cancer growth.

Authors:  Yuki Tanaka; Chikayo Iwaya; Takako Kawanami; Yuriko Hamaguchi; Tsuyoshi Horikawa; Toru Shigeoka; Toshihiko Yanase; Daiji Kawanami; Takashi Nomiyama
Journal:  Diabetol Int       Date:  2021-11-25

5.  A potent, imaging adenoviral vector driven by the cancer-selective mucin-1 promoter that targets breast cancer metastasis.

Authors:  Steven T Huyn; Jeremy B Burton; Makoto Sato; Michael Carey; Sanjiv S Gambhir; Lily Wu
Journal:  Clin Cancer Res       Date:  2009-04-14       Impact factor: 12.531

6.  Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype.

Authors:  Junichi Kurebayashi; Naoki Kanomata; Takuya Moriya; Yuji Kozuka; Mika Watanabe; Hiroshi Sonoo
Journal:  BMC Cancer       Date:  2010-10-20       Impact factor: 4.430

7.  In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity.

Authors:  Chanel E Smart; Brian J Morrison; Jodi M Saunus; Ana Cristina Vargas; Patricia Keith; Lynne Reid; Leesa Wockner; Marjan Askarian-Amiri; Marjan Askarian Amiri; Debina Sarkar; Peter T Simpson; Catherine Clarke; Chris W Schmidt; Brent A Reynolds; Sunil R Lakhani; J Alejandro Lopez
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

8.  A new human breast cancer cell line, KPL-3C, secretes parathyroid hormone-related protein and produces tumours associated with microcalcifications in nude mice.

Authors:  J Kurebayashi; M Kurosumi; H Sonoo
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

9.  Conjugated docosahexaenoic acid suppresses KPL-1 human breast cancer cell growth in vitro and in vivo: potential mechanisms of action.

Authors:  Miki Tsujita-Kyutoku; Takashi Yuri; Naoyuki Danbara; Hideto Senzaki; Yasuhiko Kiyozuka; Norihisa Uehara; Hideho Takada; Takahiko Hada; Teruo Miyazawa; Yutaka Ogawa; Airo Tsubura
Journal:  Breast Cancer Res       Date:  2004-04-26       Impact factor: 6.466

10.  Models of breast cancer: is merging human and animal models the future?

Authors:  Jong B Kim; Michael J O'Hare; Robert Stein
Journal:  Breast Cancer Res       Date:  2003-08-19       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.